AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03437720 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: Solution for injection~Route of administration: Subcutaneous injection
Study NCT02068586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunitinib
Description: Given PO
Study NCT03540524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLPG2737
Description: GLPG2737 capsules for oral use, daily.
Study NCT03735849 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC07-523LS
Description: Administered by intravenous (IV) infusion
Study NCT01318850 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy
Description: The program has a duration of 40 sessions (one hour of duration), with two sessions for week during four months. It is carried out individually and utilizes paper and pencil tasks. The main technique utilized is the scaffolding (to provide strategies when the patient cannot carry out the task and to withdraw him when he is yet able of doing it alone) in a context of learning without errors.
Study NCT01318850 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: The program has a duration of 40 sessions (one hour of duration), with two sessions for week during four months. It is carried out individually and utilizes teaching information and coping skills and neuropsychological issues are not addressed.
Study NCT01537081 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo tablets in two formulations to match either Mucinex or IR guaifenesin taken by mouth with a full glass of water
Study NCT01537081 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo tablets in two formulations to match either Mucinex or IR guaifenesin taken by mouth with a full glass of water
Study NCT02068586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valproic Acid
Description: Given PO
Study NCT02068586 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunitinib Malate
Description: Given PO
Study NCT02068586 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sunitinib Malate + Valproic Acid
Description: Given PO
Study NCT01818154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LED phototherapy
Study NCT01537081 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets in two formulations to match either Mucinex or IR guaifenesin taken by mouth with a full glass of water
Study NCT01818154 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: LED phototherapy
Study NCT01229748 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Standard Care
Description: Clients attend two 90-minute group sessions per week.Treatment lasts for three months.
Study NCT01229748 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy
Description: Multidimensional Family Therapy is an outpatient family-based treatment for troubled youth (Liddle, 2002). Treatment duration is 3 months, sessions last 60-90 minutes, with an average of 2 sessions per week and additional extrafamilial work and phone contacts as needed.
Study NCT01818154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: narrowband UVB phototherapy
Study NCT01818154 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: narrowband UVB phototherapy
Study NCT01229748 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Motivational Interviewing Intervention
Description: Youth and parents receive 2 FMII sessions in their homes within 72 hours of the ER incident, and youth will be linked with group treatment lasting 3 months.
Study NCT03726515 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CART-EGFRvIII T cells
Description: autologous T cells that have been engineered to express an extracellular Humanized single chain antibody (scFv) with specificity for EGFRvIII linked to an intracellular signaling molecule comprised of a tandem signaling domain of the 4-1BB and TCRζ signaling modules.
Study NCT03726515 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities.
Study NCT03920059 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mycophenolate Mofetil
Description: Description Each capsule contains Mycophenolate mofetil 250 mg. Presentation / Packing Cap 250 mg (white to off white powder, light blue/peach hard gelatin, imprinting with MMF on cap and 250 on body) x 10 x 10's.~Storage Store below 30 degree Celcius.
Study NCT03920059 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mycophenolate Mofetil
Description: Description Each capsule contains Mycophenolate mofetil 250 mg. Presentation / Packing Cap 250 mg (white to off white powder, light blue/peach hard gelatin, imprinting with MMF on cap and 250 on body) x 10 x 10's.~Storage Store below 30 degree Celcius.
Study NCT00244946 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: therapeutic autologous lymphocytes
Description: Lymphocytes collected by standard apheresis technique either prior to or post stem cell mobilization and collection
Study NCT03973463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Elastic knee joint movement
Description: Low resistance (7kg and 10kg) elastic band exercise 3 times a week for 12 weeks.Balanced diet reduces oil intake by 1200 calories per day. Maintains 12 weeks.Balanced diet reduces oil intake by 1200 calories per day. Maintains 12 weeks.
Study NCT03973463 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Elastic knee joint movement
Description: Low resistance (7kg and 10kg) elastic band exercise 3 times a week for 12 weeks.Balanced diet reduces oil intake by 1200 calories per day. Maintains 12 weeks.Balanced diet reduces oil intake by 1200 calories per day. Maintains 12 weeks.
Study NCT00106691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toremifene 20 mg
Description: The subject takes one dose by mouth of the 20mg Toremifine Citrate tablet once a day for the length of the trial (360 days).
Study NCT00244946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carmustine
Study NCT00106691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: The subject takes a placebo tablet identical in appearance to the toremifene 20mg tablet, administered by mouth daily for 360 days.
Study NCT03071991 — intervention group
Intervention type: PROCEDURE
Intervention: study group
Description: local anesthetic drug will be used
Study NCT03071991 — intervention group
Intervention type: PROCEDURE
Intervention: control group
Description: no local anesthetic drug will be used
Study NCT03464422 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ESTEEM conneCT
Description: The intervention adapts the ESTEEM (Pachankis et al, 2015) intervention to address the multiple-stigma stressors faced by MSM of color, including sexual orientation and racial stigma in a manualized, CBT-based intervention. Approximately thirty participants (divided between two cohorts) will complete ten group sessions will take place at regular times once per week over the course of three months. The groups will be closed, in that no new members will be allowed to join after the first week in order to promote open self-disclosure and trust among group members.
Study NCT04907435 — intervention group
Intervention type: PROCEDURE
Intervention: simultaneous operations
Description: simultaneous operations
Study NCT03208530 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief motivational interview intervention
Description: A brief (\<7minutes) interview by an emergency department clinician to empower patients to formulate and communicate their goals for medical care with patients' outpatient clinicians.
Study NCT02839902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-085
Description: Omega-3-acid ethyl esters (TAK-085) capsule
Study NCT02839902 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Not treated with omega-3-acid ethyl esters
Description: Not treated with omega-3-acid ethyl esters
Study NCT01901965 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Study NCT01901965 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Neuromuscular electrical stimulation
Study NCT01901965 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eccentric training
Study NCT01376479 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: INV21 Low Dose
Description: Inactivated EV71 vaccine containing whole viral particles of EV71 formulated with aluminum hydroxide.
Study NCT00244946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Study NCT05237414 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: 15 seconds of 2.0 mA direct current applied over the right DLPFC
Study NCT05237414 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active CT
Description: Active memory inhibition CT (i.e., training of memory inhibition specifically for alcohol-related memories).
Study NCT05237414 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham CT
Description: Sham memory inhibition CT (i.e., participants have to categorize alcoholic and non-alcoholic images but they do not have to inhibit the memories related to these images).
Study NCT01376479 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: INV21 High Dose
Description: Inactivated EV71 vaccine consisting of whole viral particles of EV71 formulated with aluminum hydroxide.
Study NCT02034539 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VADOplex system
Description: intermittent automatic pneumatic compression of the sole of the foot by the VADOplex system
Study NCT04648995 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: High energy (UltraPulse)
Description: Half of the face that receives low energy, their central base of boxcar scar will be treated with 30mJ, while shoulder of scar will be treated with 60 mJ
Study NCT00244946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Study NCT01376479 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Phosphate Buffered Saline (PBS)
Study NCT03353922 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cyclobenzaprine 10 Mg Oral Tablet
Description: cyclobenzaprine 10 mg tablets
Study NCT00244946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: melphalan
Study NCT00244946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: peripheral blood stem cell transplantation (PBSCT)
Study NCT01318850 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Healthy controls
Description: No intervention
Study NCT03353922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine 10 Mg Oral Tablet
Description: cyclobenzaprine 10 mg tablets
Study NCT03353922 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Oral Tablet
Description: sugar pill
Study NCT03353922 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: sugar pill
Study NCT03353922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Oral Tablet
Description: sugar pill
Study NCT00868530 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Xyntha
Description: Xyntha for on-demand treatment of bleeding episodes were according to investigator prescription during the 6 months observation period. The recovery assessed by determining the Factor VIII (FVIII) concentration (FVIII:C) levels in individual subjects at the initial and final visits. The dose of Xyntha for recovery assessments is: single 50 IU/kg (±5 IU/kg) IV bolus infusion. All Xyntha administrations occurred in the clinic (hospital).
Study NCT00346840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol vaginal insert 25 mcg
Description: One hydrogel polymer vaginal insert for up to 24h
Study NCT00346840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol vaginal insert 50 mcg
Description: One hydrogel polymer vaginal insert for up to 24h
Study NCT00346840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol vaginal insert 100 mcg
Description: One hydrogel polymer vaginal insert for up to 24h
Study NCT00346840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol vaginal insert 200 mcg
Description: One hydrogel polymer vaginal insert for up to 24h
Study NCT03344640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: secukinumab
Description: AIN457 300 mg subcutaneously for 12 weeks
Study NCT03344640 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match AIN457 subcutaneously for 12 weeks
Study NCT03770494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3405105
Description: Administered orally.
Study NCT00990145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDP-322
Study NCT00987324 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Taxus stent
Description: Implantation of paclitaxel-eluting stent
Study NCT00987324 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SeQuent Please
Description: Dilation with SeQuent Please (paclitaxel-eluting balloon)
Study NCT00987324 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Balloon Catheter
Description: Ryuijin, Trek
Study NCT01130298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone Gel 1.62%
Description: 5 grams
Study NCT02941094 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: needle PLT-805AT
Description: comparing success rate and complications using different needle to US probe angles.
Study NCT02941094 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: Xario, Toshiba Tokyo Japan
Study NCT00849446 — intervention group
Intervention type: DEVICE
Intervention: Activity monitor (SenseWear Pro armband)
Description: Activity monitoring during specific physical activities such as walking at different speeds
Study NCT01065532 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sequent Please Paclitaxel eluting balloon
Description: Sequent Please Paclitaxel eluting balloon
Study NCT03900897 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cochlear Implant
Description: Chart review of subjects implanted with a MED-EL cochlear implant under 6 years of age between January 2005 and October 2020.
Study NCT01190709 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Dynamic Compression Plate
Description: we made a longitudinal incision 1 cm lateral to the tibial crest, expose the fracture, and retract the muscles laterally. After determining the length of plate, we used bending instruments to contour the plate to the anatomy then threaded plate holders used to position the plate on the bone. After that we placed the drill guide at the edge of the dynamic compression unit (DCU) portion of the plate hole without applying pressure and tightening of the cortex screws results in dynamic compression. We verified the screw position with a guide wire before insertion and then inserted the locking screw.
Study NCT01190709 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Unreamed intramedullary nailing
Description: we inserted the nail, without reaming, across the fracture site, with particular attention being paid to the prevention of over distraction and the achievement of cortical contact of the fracture ends. An upper diameter limit of 10 mm and a nail measuring at least 2 mm less than the diameter measured at the isthmus of the tibia on anteroposterior and lateral radiographs were stipulated.
Study NCT01065532 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Xience V everolimus eluting stent
Description: Xience V everolimus eluting stent
Study NCT04425707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: use of Ivermectin in the treatment of COVID 19 patients, in comparison to and in addition to the standard care of treatment of COVID 19 in Egypt
Study NCT04425707 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin
Description: use of Ivermectin in the treatment of COVID 19 patients, in comparison to and in addition to the standard care of treatment of COVID 19 in Egypt
Study NCT02953327 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bacille Calmette-Guerin
Description: Vaccine against tuberculosis
Study NCT04648995 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Low energy (UltraPulse)
Description: Half of the face that receives low energy, their central base of boxcar scar will be treated with 20mJ, while shoulder of scar will be treated with 50 mJ
Study NCT00806494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fesoterodine
Description: Fesoterodine 4mg for 4 weeks, escalating to fesoterodine 8mg if tolerated
Study NCT02953327 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: BCG solvent
Description: Simple solvent
Study NCT03414723 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sotagliflozin (SAR439954)
Description: Pharmaceutical form: tablets~Route of administration: oral
Study NCT03694743 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2Shape rotary system
Description: root canal preparation
Study NCT03694743 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 2Shape rotary system
Description: root canal preparation
Study NCT02616393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tesevatinib
Study NCT04288388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: massage group
Description: In recent years, in the literature, it is known that many non-pharmacological techniques are applied to reduce the pain of birth in addition to local anesthesia. One of these nonpharmacological methods is the application of pressure to LI4 point on hand with ice.
Study NCT00019604 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: computed tomography
Description: Scan to assess the effects of ablation.
Study NCT00019604 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: magnetic resonance imaging
Description: Imaging used to assess the effects of this ablative therapy on tumor vascular density.
Study NCT00019604 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: positron emission tomography
Description: Physiology based method of imaging disease based on uptake and metabolism of radiopharmaceutical by the tissues.
Study NCT05947630 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ankle Foot Orthosis (AFO)
Description: 3D treatment (AFO will be printed) versus traditional made AFO
Study NCT05947630 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Knee Ankle Foot Orthosis (KAFO)
Description: 3D treatment (KAFO will be printed) versus traditional made KAFO
Study NCT03430271 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity Intervention
Description: Participants in this arm will complete exercise sessions 1 time per week for 24 weeks. An optional, second PA session will also be offered to PA participants. The exercise sessions will be multimodal and involve walking, lower extremity strengthening exercises, flexibility and balance training.
Study NCT03430271 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Healthy Aging Intervention
Description: Participants will attend health education workshops on topics of relevance to older adults. Workshops will be offered weekly in a group setting, and participants will be required to attend biweekly.
Study NCT00019604 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: radiofrequency ablation
Description: Radiofrequency ablation uses saline infusion into and out of needle/electrode through a closed system. More energy may be deposited without tissue-charring or gas vaporization.
Study NCT00019604 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: radionuclide imaging
Description: Imaging following injection of a radioactive material.
Study NCT00019604 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ultrasound imaging
Description: An ultrasound (e.g. sound waves) is used to identify the lesion and needle placement.
Study NCT00019604 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: fludeoxyglucose F 18 (FDG-PET)
Description: FDG PET scans rely on metabolic changes to evaluate response to therapy.
Study NCT00019604 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: gadopentetate dimeglumine
Description: Food and Drug Administration approved contrast agent.
Study NCT03212885 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation
Description: Electrode that provides electrical stimulation to deep brain structures for relief of Parkinson's Disease symptoms.
Study NCT01041443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluoro-2-deoxycytidine
Description: Given IV
Study NCT04111159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK3486
Description: Subjects \< 65 years old:Initial dose of 0.4 mg/kg followed by 0.15 mg/kg if needed;Subjects ≥ 65 years old:75% of the dose for subjects \< 65 years old.